BioProcessors Corp. Closes $18 Million Series C Round Of Funding
Published: Jun 13, 2006
Boston, MA – June 13, 2006 – HLM Venture Partners, a leading health care venture capital firm, today announced it has led an $18 million Series C equity investment in BioProcessors Corporation, the leading provider of micro-engineered solutions for biopharmaceutical process development applications for the biotechnology and pharmaceutical industries. New Science Ventures, a firm that invests in companies that leverage breakthrough science to solve major problems, also participated in the round as did existing investors Oxford Bioscience Partners and Healthcare Ventures.